| Lipid profiles
(in mg/dL) |
*d4T |
AZT |
TDF |
| N (%) |
COR |
N (%) |
p-value |
OR (95% CI) |
N (%) |
p-value |
OR (95 CI) |
| TC>200 |
3 (33.3) |
1.00 |
12 (46.2) |
0.5 |
1.7(0.4-8.4 |
17(48.6) |
0.4 |
1.9(0.4-8.8) |
| HDL-c<40 |
2 (22.2) |
1.00 |
6 (23.1) |
0.95 |
1.05(0.2-6.5) |
8(22.8) |
1.0 |
1.0(0.2-6.0) |
| LDL-c >130 |
3 (33.3) |
1.00 |
10 (38.5) |
0.6 |
1.3(0.3-6.2) |
15(42.9) |
0.4 |
1.5(0.3-7.0) |
| TG>150 |
1 (11.1) |
1.00 |
11 (42.3) |
0.1 |
5.8 (0.6-54.0) |
16(45.7) |
0.1 |
6.7(0.8-59.8) |
| TC/HDL-C >5 |
1 (11.1) |
1.00 |
7 (26.9) |
0.4 |
2.95(0.3-8.3) |
11(31.4) |
0.3 |
3.7(0.4- 33.0) |
OR = odds ratio,*reference group, TC= Total Cholesterol, HDL-c= High Density Lipoprotein -Cholesterol, LDL-c= Low Density Lipoprotein-Cholesterol, TG= Triglyceride, d4T = stavudine , AZT = zidovudine, TDF = Tenofovir Disoproxil Fumarate |
